Inventor · disambiguated record
Mark Bobko
Also filed as: BOBKO MARK · BOBKO MARK A
7 granted patents·1 pending application·184 citations·filing 2000–2009
87Inventor score
Technology areasA61P
Files withBOEHRINGER INGELHEIM PHARMA3AVENTIS PHARMA GMBH2AVENTIS PHARMA INC1SANOFI AVENTIS DEUTSCHLAND1
Top patents by PatentIndex Score
8 records- 0192US7005440B1Therapeutic uses of tri-aryl acid derivativesAVENTIS PHARMA GMBH·Filed 2000·Granted Feb 28, 2006·79 cites·56 claims
- 0291US6635655B1Therapeutic uses of di-aryl acid derivativesAVENTIS PHARMA GMBH·Filed 2000·Granted Oct 21, 2003·61 cites·25 claims
- 0385US7321041B21,6 Naphthyridines useful as inhibitors of SYK kinaseBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Jan 22, 2008·23 cites·6 claims
- 0483US7678911B21,6 naphthyridines useful as inhibitors of SYK kinaseBOEHRINGER INGELHEIM PHARMA·Filed 2008·Granted Mar 16, 2010·6 cites·2 claims
- 0583USRE40558ETherapeutic uses of di-aryl acid derivativesSANOFI AVENTIS DEUTSCHLAND·Filed 2005·Granted Oct 28, 2008·8 cites·42 claims
- 0681US7705151B21,6 Naphthridines useful as inhibitors of SYK kinaseBOEHRINGER INGELHEIM PHARMA·Filed 2009·Granted Apr 27, 2010·4 cites·2 claims
- 0767US7612075B2Substituted oxoazaheterocyclyl compoundsAVENTIS PHARMA INC·Filed 2003·Granted Nov 3, 2009·3 cites·15 claims
- 0849US2003158195A11,6 naphthyridines useful as inhibitors of SYK kinaseFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →